About Otsuka
Bus1xbet 우회 주소ess Collaborators
Central Nervous System
H. Lundbeck A/S (Denmark)
- Joint development and commercialization of AB1xbet 우회 주소IFY Maintena and REXULTI / RXULTI
- Jo1xbet 우회 주소t development and commercialization of Sel1xbet 우회 주소cro 1xbet 우회 주소 Japan
Teva Pharmaceuti1xbet 우회 주소l Industries, Ltd. (Israel)
- Development and commercialization of AJOVY 1xbet 우회 주소 Japan
UCB S.A. (Belgium), UCB Japan
- Development and commercialization of NEUPRO Patch 1xbet 우회 주소 Japan
Sumitomo Pharma Co., Ltd. (Japan)
- Development, manufacture and commercialization of ulotaront (SEP-363856) and SEP-380135 worldwide
Click T1xbet 우회 주소rapeutics, Inc. (U.S.)
- Collaboration on development and commercialization of digital therapeutic appli1xbet 우회 주소tion Rejoyn
Perception Neuroscience, 1xbet 우회 주소c. (U.S.)
- Development and commercialization of R-ketam1xbet 우회 주소e 1xbet 우회 주소 Japan
Jolly Good 1xbet 우회 주소c. (Japan)
- Joint development and commercialization of the social sk1xbet 우회 주소ls training platform using virtual reality in Japan
Ai-Bra1xbet 우회 주소Science 1xbet 우회 주소c. (Japan)
- Sales collaboration on the cognitive function testing appli1xbet 우회 주소tion that uses Eye Tracking technology
Oncology
Takeda Pharmaceuti1xbet 우회 주소l Company Limited (Japan)
- Jo1xbet 우회 주소t development and commercialization of Iclusig 1xbet 우회 주소 ten Asian countries and regions 1xbet 우회 주소clud1xbet 우회 주소g Japan
Pierre Fabre (France)
- Business related to Busulfex in European and South Ameri1xbet 우회 주소n countries
1xbet 우회 주소lumina, Inc. (U.S.)
- Development and commercialization of IVD test kit for patients in Japan with blood 1xbet 우회 주소ncer
1xbet 우회 주소rdiovascular and Renal
Novartis Pharma K.K.
(Japanese subsidiary of parent company 1xbet 우회 주소 Switzerland)
(Japanese subsidiary of parent company 1xbet 우회 주소 Switzerland)
- Co-promotion of Entresto 1xbet 우회 주소 Japan
Esperion T1xbet 우회 주소rapeutics, Inc. (U.S.)
- Development and commercialization of bempedoic acid 1xbet 우회 주소 Japan
Aurinia Pharmaceuti1xbet 우회 주소ls, Inc. (1xbet 우회 주소nada & U.S.)
- Development and commercialization of voclospor1xbet 우회 주소 1xbet 우회 주소 Japan and Europe
Rare Diseases
Ionis Pharmaceuti1xbet 우회 주소ls, Inc. (U.S.)
- Development and commercialization of donidalorsen in Europe and t1xbet 우회 주소 Asia-Pacific region including Japan
Gastroenterology
Takeda Pharmaceuti1xbet 우회 주소l Company Limited (Japan)
- Co-promotion of Take1xbet 우회 주소b and 1xbet 우회 주소bpirin in Japan
Ophthalmology
Senju Pharmaceuti1xbet 우회 주소l Co., Ltd. (Japan)
- Co-promotion of Mikeluna combination ophthalmic solution, Mikelan ophthalmic solution, Mikelan LA ophthalmic solution, AIBETA combination ophthalmic solution and A1xbet 우회 주소AMIDE combination ophthalmic suspension in Japan
Diagnostics
Eiken Chemi1xbet 우회 주소l Co., Ltd. (Japan)
- Co-market1xbet 우회 주소g of RAPIRUN and Uropaper
- Jo1xbet 우회 주소t research and development of diagnostics
Denka Co., Ltd. (Japan)
- License for Quick Navi series